FindTrial
Sign In

Study on the Predictive Value of Blood Lead for the Syntax Score in Patients with Metabolic Syndrome

Study on the Predictive Value of Blood Lead for the Syntax Score in Patients with Metabolic Syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126144
Enrollment
Unknown
Registered
2026-06-04
Start date
2026-05-16
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic syndrome

Interventions

MetS Cohort:None
Non-MetS Cohort:None

Sponsors

Beijing Anzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 80; 2. Have undergone coronary angiography due to angina pectoris or similar symptoms; 3. It meets the diagnostic criteria for metabolic syndrome (MetS).

Exclusion criteria

Exclusion criteria: 1. Congestive heart failure; 2. Coronary dilation; 3. Valvular heart disease; 4. Hyperthyroidism; 5. Chronic obstructive pulmonary disease.

Design outcomes

Primary

MeasureTime frame
Blood lead level;Syntax score;—

Countries

China

Contacts

Public ContactSun Tao

Beijing Anzhen Hospital

taomayoclinic@sina.com+86 135 2080 8537

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026